These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9326982)

  • 1. The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.
    Burn J; Camm J; Davies MJ; Peltonen L; Schwartz PJ; Watkins H
    Heart; 1997 Aug; 78(2):110-6. PubMed ID: 9326982
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome.
    Vincent GM
    Heart; 2001 Jul; 86(1):12-4. PubMed ID: 11410552
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
    Maron BJ; Moller JH; Seidman CE; Vincent GM; Dietz HC; Moss AJ; Sondheimer HM; Pyeritz RE; McGee G; Epstein AE
    Circulation; 1998 Oct; 98(14):1460-71. PubMed ID: 9841131
    [No Abstract]   [Full Text] [Related]  

  • 4. AHA assesses the impact of genotyping on diagnosis of genetic cardiac disease. American Heart Association.
    Morey SS
    Am Fam Physician; 1999 May; 59(10):2915-6, 2918. PubMed ID: 10348078
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of molecular genetics on clinical cardiology.
    Mayosi BM; Watkins H
    J R Coll Physicians Lond; 1999; 33(2):124-31. PubMed ID: 10340258
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?
    Ackerman MJ
    Curr Opin Cardiol; 2005 May; 20(3):175-81. PubMed ID: 15861004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of heart disease. Synopsis of the pathophysiological basis of cardiac hypertrophy, familial hypertrophic cardiomyopathy, long QT syndrome and Marfan syndrome.
    Kurabayashi M; Yazaki Y
    Intern Med; 1996 Apr; 35(4):243-8. PubMed ID: 8739775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetics of cardiovascular diseases].
    Schunkert H; Hense HW
    Dtsch Med Wochenschr; 1995 Apr; 120(15):533-9. PubMed ID: 7720536
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy.
    Knight LM; Miller E; Kovach J; Arscott P; von Alvensleben JC; Bradley D; Valdes SO; Ware SM; Meyers L; Travers CD; Campbell RM; Etheridge SP
    Heart Rhythm; 2020 Jan; 17(1):106-112. PubMed ID: 31229680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic testing for inherited cardiac arrhythmias.
    Fowler SJ; Cerrone M; Napolitano C; Priori SG
    Hellenic J Cardiol; 2010; 51(2):92-103. PubMed ID: 20378510
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetics of cardiovascular disease.
    Cymet T
    Compr Ther; 2010; 36():18-9. PubMed ID: 21229815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening children with a family history of sudden cardiac death.
    Wren C
    Heart; 2006 Jul; 92(7):1001-6. PubMed ID: 16775115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gene tests in cardiac rhythm disturbances--new international expert recommendations].
    Swan H
    Duodecim; 2012; 128(7):697-704. PubMed ID: 22612020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Association of a De Novo CALM2 Mutation With Long QT Syndrome and Hypertrophic Cardiomyopathy.
    Zahavich L; Tarnopolsky M; Yao R; Mital S
    Circ Genom Precis Med; 2018 Oct; 11(10):e002255. PubMed ID: 30354306
    [No Abstract]   [Full Text] [Related]  

  • 15. Uptake of Predictive Genetic Testing and Cardiac Evaluation for Children at Risk for an Inherited Arrhythmia or Cardiomyopathy.
    Christian S; Atallah J; Clegg R; Giuffre M; Huculak C; Dzwiniel T; Parboosingh J; Taylor S; Somerville M
    J Genet Couns; 2018 Feb; 27(1):124-130. PubMed ID: 28699125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of hereditary cardiopathies].
    Debrus S; de Meeus A; Jean MK; Bouvagnet P
    Arch Mal Coeur Vaiss; 1996 May; 89(5):619-27. PubMed ID: 8758572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marfan syndrome, hypertrophic cardiomyopathy findings underline avoidance of some sports.
    Goldsmith MF
    JAMA; 1992 Dec 23-30; 268(24):3413-4. PubMed ID: 1460723
    [No Abstract]   [Full Text] [Related]  

  • 18. Cosegregation of the Marfan syndrome and the long QT syndrome in the same family leads to a severe cardiac phenotype.
    Probst V; Allouis M; Kyndt F; Lande G; Trochu JN; Schott JJ; Le Marec H
    Am J Cardiol; 2003 Mar; 91(5):635-7. PubMed ID: 12615283
    [No Abstract]   [Full Text] [Related]  

  • 19. Entwining electrical and hypertrophic cardiomyopathies.
    Alexander M
    Heart Rhythm; 2005 Dec; 2(12):1369-70. PubMed ID: 16360094
    [No Abstract]   [Full Text] [Related]  

  • 20. Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and Long QT syndrome: a qualitative study of patient experiences.
    Smart A
    J Genet Couns; 2010 Dec; 19(6):630-9. PubMed ID: 20680418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.